Betaxolol Tablet, Film Coated
Product Images NDC 42806-038

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Betaxolol (NDC 42806-038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epic Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Betaxolol-10mg-100s (Betaxolol 10mg 100s)

Packaging label for Betaxolol Tablets USP 10 mg, film-coated oral tablets. The label states each tablet contains 10 mg betaxolol hydrochloride (equivalent to 8.94 mg betaxolol). The product is Rx only, supplied as 100 film-coated tablets, and manufactured by Epic Pharma LLC, Laurelton, NY. The label includes dosage storage instructions and a barcode.*

FDA Label Image

Betaxolol-20mg-100s (Betaxolol 20mg 100s)

Label for Betaxolol Tablets USP 20 mg, oral film-coated tablets, manufactured by Epic Pharma LLC. The label includes dosage notes, storage instructions, and the NDC number 42806-039-01. The package contains 100 film-coated tablets. The label features the Epic Pharma logo and specifies that each tablet contains 20 mg betaxolol hydrochloride, equivalent to 17.88 mg betaxolol base.*

FDA Label Image

Molecular Weight 343.9 (Image 01)

Chemical structure of Betaxolol hydrochloride shown as a molecular diagram with aromatic ring, ether linkages, hydroxyl group, amine group, and cyclopropyl moiety.*

FDA Label Image

Table-1 (Table 1)

This is a data table presenting the incidence percentages of various adverse reactions across different body systems for Betaxolol (5-40 mg, q.d.), Propranolol (40-160 mg, b.i.d.), Atenolol (25-100 mg, q.d.), and Placebo. The table categorizes reactions by cardiovascular, central nervous system, psychiatric, autonomic, respiratory, gastrointestinal, musculoskeletal, and skin systems with incidence rates for each drug and placebo group.*

FDA Label Image

Table-2 (Table 2)

A data table comparing the percentage of adverse reactions in patients taking Betaxolol 20-40 mg once daily, Atenolol 100 mg once daily, and a placebo. The table categorizes adverse reactions by body system, including cardiovascular, central nervous system, gastrointestinal, and musculoskeletal, listing specific symptoms and their incidence rates for each treatment group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.